These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. NUCLEOSIDE ANTIBIOTICS RELATED TO ADENOSINE. BLOCH A; NICHOL CA Antimicrob Agents Chemother (Bethesda); 1964; 10():530-9. PubMed ID: 14287987 [No Abstract] [Full Text] [Related]
3. Clinical studies with amicetin. TAN CT; BURCHENAL JH Antibiotic Med Clin Ther (New York); 1956 Jul; 3(2):126-31. PubMed ID: 13340692 [No Abstract] [Full Text] [Related]
4. [On the antineoplastic action of derivatives of blasticidin S]. KATO M; SAITO G; KAGIWADA K; TAKAGI K; SHIRATO S; SAKAI S J Antibiot B; 1963 Feb; 16():1-3. PubMed ID: 14042114 [No Abstract] [Full Text] [Related]
5. Isolation and structure determination of a new amicetin-like antibiotic: amicetin B. SENSI P; GRECO AM; GALLO GG; ROLLAND G Antibiot Chemother (Northfield); 1957 Dec; 7(12):645-52. PubMed ID: 24544597 [No Abstract] [Full Text] [Related]
6. [Studies on the structure of gougerotin. (2) Components of gougerotin]. IWASAKI H Yakugaku Zasshi; 1962 Oct; 82():1361-5. PubMed ID: 13964243 [No Abstract] [Full Text] [Related]
7. GOUGEROTIN, A SPECIFIC INHIBITOR OF PROTEIN SYNTHESIS. CLARK JM; GUNTHER JK Biochim Biophys Acta; 1963 Dec; 76():636-8. PubMed ID: 14099625 [No Abstract] [Full Text] [Related]
8. EFFECT OF GOUGEROTIN ON THE PROTEIN SYNTHESIS IN THE MOUSE LIVER. SINOHARA H; SKY-PECK HH Biochem Biophys Res Commun; 1965 Jan; 18():98-102. PubMed ID: 14265765 [No Abstract] [Full Text] [Related]
9. TUBERCIDIN. DUVALL LR Cancer Chemother Rep; 1963 Jul; 30():61-2. PubMed ID: 14051507 [No Abstract] [Full Text] [Related]
10. [Studies on the structure of gougerotin. (9). the steric configuration of C substance]. IWASAKI H Yakugaku Zasshi; 1962 Oct; 82():1387-90. PubMed ID: 13961801 [No Abstract] [Full Text] [Related]
11. TENUAZONIC ACID. DUVALL LR Cancer Chemother Rep; 1963 Jul; 30():55-6. PubMed ID: 14051505 [No Abstract] [Full Text] [Related]
12. [Studies on the structure of gougerotin. (10). Structure of seryl-C substance]. IWASAKI H Yakugaku Zasshi; 1962 Oct; 82():1390-2. PubMed ID: 13957107 [No Abstract] [Full Text] [Related]
13. [Studies on the structure of gougerotin. (7). Structure of sugar moiety of C substance. (ii). Isolation of hyxosamine]. IWASAKI H Yakugaku Zasshi; 1962 Oct; 82():1380-3. PubMed ID: 13964246 [No Abstract] [Full Text] [Related]
14. [Studies on the structure of gougerotin. (6) Structure of sugar moiety of C substance. (i). Isolation of uronic acid]. IWASAKI H Yakugaku Zasshi; 1962 Oct; 82():1376-80. PubMed ID: 13964245 [No Abstract] [Full Text] [Related]
15. [Studies on the structure of gougerotin. (5) Position of the side chain of C substance]. IWASAKI H Yakugaku Zasshi; 1962 Oct; 82():1372-6. PubMed ID: 13964244 [No Abstract] [Full Text] [Related]
16. [Studies on the structure of gougerotin. (8). Structure of sugar moiety of C substance. (iii). Position of amino group]. IWASAKI H Yakugaku Zasshi; 1962 Oct; 82():1384-6. PubMed ID: 13964247 [No Abstract] [Full Text] [Related]
17. [Studies on the structure of gougerotin. (1) Properties of gougerotin]. IWASAKI H Yakugaku Zasshi; 1962 Oct; 82():1358-61. PubMed ID: 13964242 [No Abstract] [Full Text] [Related]
18. PORFIROMYCIN. DUVALL LR Cancer Chemother Rep; 1963 Jul; 30():35-43. PubMed ID: 14051502 [No Abstract] [Full Text] [Related]
19. Cloning, heterologous expression, and characterization of the gene cluster required for gougerotin biosynthesis. Niu G; Li L; Wei J; Tan H Chem Biol; 2013 Jan; 20(1):34-44. PubMed ID: 23352137 [TBL] [Abstract][Full Text] [Related]